The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its…

The 150-year-old drugmaker is the first company in health care to hit the milestone.

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.

A new analysis found that nearly 700 drugs approved for use in the United States depend on chemicals solely produced in China.

Acetaminophen’s link to autism is unproven. But hundreds of Americans accidentally overdose on the drug each year, suffering liver damage that can require a transplant…

President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs…

The president said he would impose a tariff of 100 percent on certain brand-name drugs. Here’s what we know so far.

Big companies like Novartis say new tariffs won’t hit them. “A win for Pharma,” Wall Street analysts said.

Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever…